Impact BioMedical (IBO) Announces 3F US Patent Issue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue
September 26, 2024 8:30 AM EDTHOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (IBO) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled Insect Repelling Composition developed within IBOs 3F technology platform.
This is in addition to IBOs prior granted U.S. Patent No. 11,246,310. Both patents include compositions and formulations of constituents found in plants and fragrances produced by plants, which, when applied as a natural insect repellent, have the potential to reduce insect landings and bites experienced in an outdoor environment. The terms of U.S. Patents 11,985,973 and 11,246,310 will expire in February 2039 and April... More



